Correlation of claims based and patient reported pad use for incontinence one year after radical prostatectomy von Baas, D.J.H., Reitsma, J., Van Gerwen, L., Vleghaar, J., Gehlen, J., Ziedses Des Plantes, C.M.P., Van Basten, J.P.A., Van Den Bergh, R., Bruins, H.M., Collette, E.R.P., Hoekstra, R.J., Knipscheer, B.C., Van Leeuwen, P.J., Luijendijk-De Bruin, D., Van Roermund, J.G.H., Sedelaar, J.P.M., Speel, T.G.W., Stomps, S.P., Wijburg, C.J., Wijn, R.P.W.F., De Jong, I.J., Somford, D.M.

Volltext

383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer von Hendriks, R.J, Dijkstra, S, Trooskens, G, Van Criekinge, W, Cornel, E.B, Jannink, S.A, De Jong, H, Hessels, D, Smit, F.P, Melchers, W.J.G, Leyten, G.H.J.M, De Reijke, T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Hulsbergen-Van De Kaa, C.A, Mulders, P.F.A, Van Oort, I.M, Van Neste, L, Schalken, J.A

Volltext

351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer von Leyten, G.H.J.M, Hessels, D, Jannink, S.A, Smit, F.P, De Jong, H, Melchers, W.J.G, Cornel, E.B, De Reijke, T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Hulsbergen-Van De Kaa, C.A, Mulders, P.F.A, Van Oort, I.M, Schalken, J.A

Volltext

913 Prospective multicenter evaluation of PCA3+TMPRSS2-ERG as a diagnostic and prognostic marker panel for prostate cancer von Leyten, G.H.J.M, Hessels, D, Cornel, E.B, De, Reijke T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Van Oort, I.M, Mulders, P.F.A, Schalken, J.A

Volltext

122 BIOCHEMICAL OUTCOME OF PT3 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY von Van Oort, I.M, Kok, D.E, Kiemeney, L.A, Knipscheer, B.C, Mulders, P.F, Hulsbergen-Van de Kaa, C.A, Witjes, J.A

Volltext